Allarity Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Allarity Therapeutics Depreciation & Amortization Growth & History (ALLR)
Allarity Therapeutics's depreciation and amortization was −$13,000 for fiscal 2025.
View full Allarity Therapeutics company overviewAllarity Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$13,000 | −$22,000 | — |
| 2024 | 2024-12-31 | $9,000 | −$28,000 | −75.68% |
| 2023 | 2023-12-31 | $37,000 | −$23,000 | −38.33% |
| 2022 | 2022-12-31 | $60,000 | −$46,000 | −43.40% |
| 2021 | 2021-12-31 | $106,000 | $60,000 | +130.43% |
| 2020 | 2020-12-31 | $46,000 | — | — |
Allarity Therapeutics quarterly depreciation and amortization
Q3.20
Q1.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $34,000 | $22,000 | +183.33% |
| Q1 2026 | 2026-03-31 | −$26,000 | −$37,000 | — |
| Q4 2025 | 2025-12-31 | $8,000 | — | — |
| Q3 2025 | 2025-09-30 | −$44,000 | −$49,000 | — |
| Q2 2025 | 2025-06-30 | $12,000 | $11,000 | +1100.00% |
| Q1 2025 | 2025-03-31 | $11,000 | $9,000 | +450.00% |
| Q3 2024 | 2024-09-30 | $5,000 | −$4,000 | −44.44% |
| Q2 2024 | 2024-06-30 | $1,000 | −$8,000 | −88.89% |
| Q1 2024 | 2024-03-31 | $2,000 | −$8,000 | −80.00% |
| Q3 2023 | 2023-09-30 | $9,000 | −$2,000 | −18.18% |
| Q2 2023 | 2023-06-30 | $9,000 | −$15,000 | −62.50% |
| Q1 2023 | 2023-03-31 | $10,000 | −$13,000 | −56.52% |
| Q3 2022 | 2022-09-30 | $11,000 | −$26,000 | −70.27% |
| Q2 2022 | 2022-06-30 | $24,000 | — | — |
| Q1 2022 | 2022-03-31 | $23,000 | −$33,000 | −58.93% |
| Q3 2021 | 2021-09-30 | $37,000 | −$1,000 | −2.63% |
| Q1 2021 | 2021-03-31 | $56,000 | — | — |
| Q3 2020 | 2020-09-30 | $38,000 | — | — |
Allarity Therapeutics depreciation and amortization trends
Over the last five fiscal years, Allarity Therapeutics's depreciation and amortization decreased from $46,000 to −$13,000, a change of −$59,000. The latest reported quarter, Q2 2026, shows $34,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Allarity Therapeutics source filings ↗